Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Mol Cancer Ther. 2015 May 11;14(7):1521–1531. doi: 10.1158/1535-7163.MCT-15-0100

Figure 2.

Figure 2

HA-PEI/siRNA mediated MDR-1 and PKM-2 gene silencing in SKOV-3WT (A) and SKOV-3TR (B). Cells were treated with scramble, naked siRNA, siRNA formulated in Lipofectamine and siRNA formulated in HA-PEI/PEG nanoparticles. MDR-1 and PKM-2 expression was measured by qPCR. Data represented as a mean SD (n=3). (C) Cytotoxicity assay following single and combination therapy in SKOV-3WT (left) and SKOV-3TR cells (right).